Zobrazeno 1 - 10
of 158
pro vyhledávání: '"Thomas Morel"'
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
ObjectivesThe objective of this research was to generate psychometric evidence supporting the myasthenia gravis (MG) symptoms patient-reported outcome (PRO) scales as a fit-for-purpose measure of severity of core symptoms of MG and provide informatio
Externí odkaz:
https://doaj.org/article/bec1fe3766134ae297bd3459e552a7f8
Autor:
Thomas Morel, Karlin Schroeder, Sophie Cleanthous, John Andrejack, Geraldine Blavat, William Brooks, Lesley Gosden, Carroll Siu, Natasha Ratcliffe, Ashley F. Slagle
Publikováno v:
Research Involvement and Engagement, Vol 9, Iss 1, Pp 1-14 (2023)
Abstract Background In support of UCB pharmaceutical research programs, the aim of this research was to implement a novel process for patient involvement in a multidisciplinary research group to co-create a clinical outcome assessment strategy to acc
Externí odkaz:
https://doaj.org/article/bbc7b22a7386418a96f27791fe69c63a
Autor:
Antoine Regnault, Thomas Morel, Christine de la Loge, Flora Mazerolle, Henry J. Kaminski, Ali A. Habib
Publikováno v:
Neurology and Therapy, Vol 12, Iss 5, Pp 1573-1590 (2023)
Abstract Introduction Accurate measurement of myasthenia gravis (MG) severity is required for appropriate clinical monitoring of patients with MG and assessment of the benefit of new treatments in clinical trials. Our objective was to explore how MG
Externí odkaz:
https://doaj.org/article/131a281df393491aae95d0337bb8b940
Autor:
Thomas Morel, Sophie Cleanthous, John Andrejack, Roger A. Barker, Milton Biagioni, Geraldine Blavat, Bastiaan R. Bloem, Babak Boroojerdi, William Brooks, Paul Burns, Stefan Cano, Casey Gallagher, Lesley Gosden, Carroll Siu, Ashley F. Slagle, Natasha Ratcliffe, Karlin Schroeder
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-14 (2023)
Abstract Background Previous research on concepts that are important to people living with early-stage Parkinson’s indicated that ‘functional’ slowness, fine motor skills, and subtle gait abnormalities are cardinal concepts that are not compreh
Externí odkaz:
https://doaj.org/article/975eae7a59ad422a84522de47e09f322
Autor:
Thomas Morel, Karlin Schroeder, Sophie Cleanthous, John Andrejack, Geraldine Blavat, William Brooks, Lesley Gosden, Carroll Siu, Natasha Ratcliffe, Ashley F. Slagle
Publikováno v:
Research Involvement and Engagement, Vol 10, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/1cf66a2ecc504b3c811c1e3106b79be9
Autor:
Antoine Regnault, Thomas Morel, Christine de la Loge, Flora Mazerolle, Henry J. Kaminski, Ali A. Habib
Publikováno v:
Neurology and Therapy, Vol 12, Iss 5, Pp 1591-1592 (2023)
Externí odkaz:
https://doaj.org/article/eef46f92da184ba4b2e904e065f2cf8f
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Deprescribing literature has been increasing rapidly. Our aim was to develop and validate search filters to identify articles on deprescribing in Medline via PubMed and in Embase via Embase.com . Methods Articles published from 20
Externí odkaz:
https://doaj.org/article/7f69b51cf2454e4f8fe2510b74bcba38
Autor:
Sophie Cleanthous, Ann-Christin Mork, Antoine Regnault, Stefan Cano, Henry J. Kaminski, Thomas Morel
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-14 (2021)
Abstract Background Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disease, characterised by fluctuating muscle weakness which makes it challenging to assess symptom severity. Mixed methods psychometrics (MMP), which combines evidence f
Externí odkaz:
https://doaj.org/article/307ef65081e44c5291c66c41d7f2e187
Autor:
Maxime Moniot, Rose-Anne Lavergne, Thomas Morel, Romain Guieze, Florent Morio, Philippe Poirier, Céline Nourrisson
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Filamentous basidiomycetes are mainly considered to be respiratory tract colonizers but the clinical significance of their isolation in a specimen is debatable. Hormographiella aspergillata was first reported as a human pathogen i
Externí odkaz:
https://doaj.org/article/1b5609410acf490fb33a22410dd652b0
Autor:
Kirstie Haywood, Ameeta Retzer, Anita Slade, Melanie Calvert, Jane Blazeby, Rebecca Mercieca-Bebber, Antonia Bennett, Carolyn Ells, Gary Price, Galina Velikova, Heather Draper, Dennis Revicki, Julia Brown, Lori Frank, Madeleine King, Jane Scott, Sandra Mitchell, Grace Turner, Michael Brundage, Andrew Bottomley, Michael Palmer, Richard Stephens, Ingolf Griebsch, Donald Patrick, Lari Wenzel, Daniel O'Connor, Robert M Golub, Olalekan Aiyegbusi, E Basch, Jill Bell, Vishal Bhatnagar, Lisa Campbell, Amylou C Dueck, Amanda Hunn, Bellinda King-Kallimanis, Thomas Morel, Linda Nelson, Josephine Norquist, Antoine Regnault, Antonia Valakas, Maria von Hildebrand, Anita Walker
Publikováno v:
BMJ Open, Vol 11, Iss 6 (2021)
Patient-reported outcomes (PROs) are used in clinical trials to provide valuable evidence on the impact of disease and treatment on patients’ symptoms, function and quality of life. High-quality PRO data from trials can inform shared decision-makin
Externí odkaz:
https://doaj.org/article/781a2d9ef823452cb74c4e858f349f4c